General Information
Revision date
2017-07-17
Product name
Vigabatrin for Oral Solution, USP 500 mg
CAS No.
60643-86-9
1.2.1 Relevant identified uses
Vigabatrin is used for the treatment of refractory complex partial seizures in adults. It is indicated as an adjunctive therapy in patients that fail to respond to other therapies. It is also used to treat infantile spasms in children 1 month to 2 years
Emergency telephone
1-845-425-7100
Icons in SDS
Company Information
company name
Par Pharmaceutical
GHS Information
Signal word
Danger
Section 2
Health hazards
Classified. Skin corrosion/irritation Category 2 Serious eye damage/eye irritation Category 2A Reproductive toxicity Category 1B
Physical hazards
Not classified. OSHA Regulatory Status This product is considered hazardous by the 2012 OSHA Hazard Communication Standard/Globally Harmonized System of Classification and Labelling of Chemicals (GHS); (29 CFR 1910.1200; Revision 3).
2.2 Label elements
Emergency Overview Danger
Hazard statements
Causes skin irritation. Causes serious eye irritation. May damage fertility or the unborn child. Appearance Solution Physical state Liquid Odor Not available.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Use personal protective equipment as required. Wash face, hands and any exposed skin thoroughly after handling.
Response
If exposed or concerned: Get medical attention. Specific treatment (see on this label) If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical attention. If on skin: Wash with plenty of soap and water If skin irritation occurs: Get medical attention. Take off contaminated clothing and wash it before reuse.
Storage
Store locked up.
Precautionary statements
Disposal Dispose of contents/container in compliance with state and local regulations
2.3 Other hazards
None.